Antimicrobial Resistance Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Intestinal Microbiota and Antimicrobial Resistance
Condition: Drug Resistance, Microbial Intervention: Sponsor: Chinese University of Hong Kong Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 7, 2019 Category: Research Source Type: clinical trials
Intestinal Microbiota and Antimicrobial Resistance in Hong Kong Residents After Travel
Condition: Antimicrobial Resistance Intervention: Sponsor: Chinese University of Hong Kong Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 7, 2019 Category: Research Source Type: clinical trials
Intestinal Microbiota and Antimicrobial Resistance
Condition: Drug Resistance, Microbial Intervention: Sponsor: Chinese University of Hong Kong Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 7, 2019 Category: Research Source Type: clinical trials
Intestinal Microbiota and Antimicrobial Resistance in Hong Kong Residents After Travel
Condition: Antimicrobial Resistance Intervention: Sponsor: Chinese University of Hong Kong Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 7, 2019 Category: Research Source Type: clinical trials
Intestinal Microbiota and Antimicrobial Resistance
Condition: Drug Resistance, Microbial Intervention: Sponsor: Chinese University of Hong Kong Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 7, 2019 Category: Research Source Type: clinical trials
Intestinal Microbiota and Antimicrobial Resistance in Hong Kong Residents After Travel
Condition: Antimicrobial Resistance Intervention: Sponsor: Chinese University of Hong Kong Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 7, 2019 Category: Research Source Type: clinical trials
Intestinal Microbiota and Antimicrobial Resistance
Condition: Drug Resistance, Microbial Intervention: Sponsor: Chinese University of Hong Kong Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 7, 2019 Category: Research Source Type: clinical trials
Intestinal Microbiota and Antimicrobial Resistance in Hong Kong Residents After Travel
Condition: Antimicrobial Resistance Intervention: Sponsor: Chinese University of Hong Kong Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 7, 2019 Category: Research Source Type: clinical trials
Intestinal Microbiota and Antimicrobial Resistance
Condition: Drug Resistance, Microbial Intervention: Sponsor: Chinese University of Hong Kong Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 7, 2019 Category: Research Source Type: clinical trials
Intestinal Microbiota and Antimicrobial Resistance in Hong Kong Residents After Travel
Condition: Antimicrobial Resistance Intervention: Sponsor: Chinese University of Hong Kong Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 7, 2019 Category: Research Source Type: clinical trials
Intestinal Microbiota and Antimicrobial Resistance
Condition: Drug Resistance, Microbial Intervention: Sponsor: Chinese University of Hong Kong Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 7, 2019 Category: Research Source Type: clinical trials
ALternatives To prophylactic Antibiotics for the treatment of Recurrent urinary tract infection in women (ALTAR): study protocol for a multicentre, pragmatic, patient-randomised, non-inferiority trial
DiscussionThe study was commissioned and funded by the National Institute for Health Research (NIHR) and approved under the Medicines and Healthcare products Regulatory Agency (MHRA) notification scheme as a ‘Type A’ study.Trial registrationInternational Standard Randomised Controlled Trial Number (ISRCTN), registry number:ISRCTN70219762. Registered on 31 May 2016. (Source: Trials)
Source: Trials - November 9, 2018 Category: Research Source Type: clinical trials
Long-term Staphylococcus aureus decolonization in patients on home parenteral nutrition: study protocol for a randomized multicenter trial
DiscussionThe CARRIER trial is designed to identify the most safe and effective long-termS. aureus carriage decolonization strategy in HPN patients. This will eventually lead to a better understanding of long-termS. aureus decolonization treatments in general. The results of this study will have a great impact on our daily clinical practice, which eventually may result in lessS. aureus-related infections.Trial registrationClinicalTrials.gov;NCT03173053. Registered on 1 June 2017. (Source: Trials)
Source: Trials - June 28, 2018 Category: Research Source Type: clinical trials
